Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.

Author: AliMohammed K, BurgioKathryn L, ErniSusanne M, GoodePatricia S, JohnsonTheodore M, MarklandAlayne D, MirkAnna, OkosunIke, PlantingaLaura, SuvadaKara, VaughanCamille P, YoungHenry

Paper Details 
Original Abstract of the Article :
The goal of this study was to determine if the US adult population with nocturia (waking from sleep at night to void) can easily take medications (desmopressin acetate) approved by the US Food and Drug Administration for nocturia. The study examined: (1) the prevalence of comorbid conditions, labora...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/33257091

データ提供:米国国立医学図書館(NLM)

Nocturia: A Common Challenge for Older Adults

This study explores the challenges associated with nocturia, a condition characterized by frequent nighttime urination. The authors investigate the prevalence of comorbid conditions, laboratory abnormalities, and medications that may limit the use of desmopressin acetate, the only FDA-approved medication for nocturia, in older adults. Their research delves into the complexities of managing nocturia in this age group, highlighting the need for careful consideration of individual patient factors.

Navigating the Complexities of Nocturia

The study found that a significant proportion of older adults with nocturia have comorbid conditions and are taking medications that may increase the risk of desmopressin use. These findings emphasize the need for a comprehensive evaluation of individual patients, considering their medical history, current medications, and potential risks and benefits of desmopressin therapy. The authors also highlight the importance of considering the frequency of nocturia and its impact on quality of life when making treatment decisions.

Managing Nocturia: A Personalized Approach

Managing nocturia in older adults requires a tailored approach, taking into account the unique characteristics of each individual. This research provides valuable insights into the factors that may limit the use of desmopressin acetate, underscoring the importance of a comprehensive assessment before initiating treatment. By understanding the individual patient's needs and limitations, we can develop personalized treatment plans that promote optimal sleep and well-being.

Dr.Camel's Conclusion

Nocturia can be a challenging desert to navigate, especially for older adults who may have complex medical histories and medication regimens. This research sheds light on the factors that may influence treatment options, reminding us of the need for careful consideration and a personalized approach to managing this common condition.

Date :
  1. Date Completed 2021-05-20
  2. Date Revised 2022-02-05
Further Info :

Pubmed ID

33257091

DOI: Digital Object Identifier

NIHMS1700164

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.